The lung cancer surgery market is growing, expected to reach USD 7.9 billion by 2032.

From GlobeNewswire: 2024-11-25 09:00:00

Market Overview

The lung cancer surgery market is growing, estimated at USD 5.4 billion in 2023 and expected to reach USD 7.9 billion by 2032, with a CAGR of 4.3%. Demand for minimally invasive procedures and advanced surgical systems is increasing, with North America leading the market and Asia-Pacific showing the fastest growth due to rising healthcare infrastructure and awareness.

Key Players:
Accuray Incorporated, GE Healthcare, Johnson and Johnson, Olympus Corporation, Siemens Healthineers AG, Ethicon Endo Surgery Inc., Richard Wolf GMBH, Scanlan International Inc., Angiodynamics, Neomend Inc., Trokamed GMBH, Covidien, BSD Medical Corp., among others.

Segment Analysis:
Robotic-assisted surgery systems led the market in 2023, with monitoring & visualizing systems growing rapidly. Minimally invasive surgery dominated, while lobectomy was the top procedure. Hospitals were the main end-user, but ambulatory surgical centers are gaining traction for cost-effectiveness.

Regional Analysis:
North America led in 2023, driven by advanced technologies and industry leaders like Intuitive Surgical Inc. Asia-Pacific is the fastest-growing region, with countries like China and India adopting cutting-edge surgical techniques. Companies are expanding in this region to meet the rising demand for thoracic robotic surgery. Research Methodology includes top-down and bottom-up approaches, data validation through primary interviews. Market Dynamics Impact Analysis covers factors, PESTLE analysis, and Porter’s Five Forces. Statistical insights include incidence, prevalence, prescription trends, device volume, and healthcare spending. Competitive landscape features major companies, market share analysis, product benchmarking, and strategic initiatives.

The Lung Cancer Surgery Market is segmented by product type, surgery type, procedure, cancer stage, and end-user. Regional analysis and company profiles are included, along with use cases and best practices. For deeper insights, speak with an expert analyst today or request customization research via email. S&S Insider is a leading market research agency providing clients with accurate data and insights to make confident decisions in a changing market environment.



Read more at GlobeNewswire: Lung Cancer Surgery Market to Surpass USD 7.9 Billion by